Abstract
Seven hundred thirty-two female urogenital samples were collected for Chlamydia trachomatis testing by both the Sanofi Diagnostics Pasteur (Chaska, Minn.) Chlamydia Microplate EIA by the shortened protocol and the Syva (San Jose, Calif.) MicroTrak II EIA, and the results were compared with those obtained by cell culture. For the analysis of samples from female patients, the patients were divided into high- and low-risk categories. An additional 121 male urethral samples were collected and tested by the Sanofi Microplate EIA and cell culture; for the analysis of samples from male patients, the patients were divided into asymptomatic and symptomatic categories. All specimens positive by enzyme immunoassay (EIA) were confirmed by a blocking assay following the respective manufacturer's instructions. Specimens negative by EIA that fell within a gray zone 30% below the cutoff and negative cultures with one or more corresponding positive EIA results were tested further by cytocentrifugation and direct immunofluorescent assay. The overall sensitivity, specificity, positive predictive value, and negative predictive value for Syva versus culture were 94, 98.8, 85.5 and 99.6%, respectively. After resolution, the results were 94.5, 99.6, 94.5, and 99.6%, respectively. The parallel results for the Sanofi Microplate EIA versus culture were 94.0, 98.7, and 83.9, and 99.6%, respectively, and after being resolved, the results were 94.9, 100, 100, and 99.6%, respectively. In the small male population tested, the resolved results of the Sanofi Microplate EIA versus culture demonstrated sensitivity, specificity, positive predictive value, and negative predictive value of 100, 100, 100, and 100%, respectively. The present study demonstrated that the Sanofi Microplate EIA shortened protocol is highly sensitive and specific in comparison with cell culture and the Syva MicroTrak II EIA.
Full Text
The Full Text of this article is available as a PDF (155.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bass C. A., Jungkind D. L., Silverman N. S., Bondi J. M. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol. 1993 Oct;31(10):2648–2653. doi: 10.1128/jcm.31.10.2648-2653.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bauwens J. E., Clark A. M., Stamm W. E. Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol. 1993 Nov;31(11):3023–3027. doi: 10.1128/jcm.31.11.3023-3027.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chan E. L., Brandt K., Kozoriz D., Mushanski L., Spence C., Horsman G. B. The use of a confirmatory assay to increase the sensitivity and specificity of the Chlamydiazyme test. Am J Clin Pathol. 1994 Dec;102(6):724–728. doi: 10.1093/ajcp/102.6.724. [DOI] [PubMed] [Google Scholar]
- Chernesky M. A., Jang D., Lee H., Burczak J. D., Hu H., Sellors J., Tomazic-Allen S. J., Mahony J. B. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol. 1994 Nov;32(11):2682–2685. doi: 10.1128/jcm.32.11.2682-2685.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher M., Swenson P. D., Risucci D., Kaplan M. H. Chlamydia trachomatis in suburban adolescents. J Pediatr. 1987 Oct;111(4):617–620. doi: 10.1016/s0022-3476(87)80134-8. [DOI] [PubMed] [Google Scholar]
- Holmes K. K. The Chlamydia epidemic. JAMA. 1981 May 1;245(17):1718–1723. [PubMed] [Google Scholar]
- Kellogg J. A., Seiple J. W., Stroll E. S. Direct fluorescent-antibody confirmation of chlamydial antigen below the detection threshold of the chlamydiazyme enzyme-linked immunosorbent assay. J Clin Microbiol. 1993 Jun;31(6):1646–1647. doi: 10.1128/jcm.31.6.1646-1647.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leonardi G. P., Seitz M., Edstrom R., Cruz J., Costello P., Szabo K. Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males. J Clin Microbiol. 1992 Nov;30(11):2793–2796. doi: 10.1128/jcm.30.11.2793-2796.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moncada J., Schachter J., Bolan G., Nathan J., Shafer M. A., Clark A., Schwebke J., Stamm W., Mroczkowski T., Seliborska Z. Evaluation of Syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimens. Diagn Microbiol Infect Dis. 1992 Nov-Dec;15(8):663–668. doi: 10.1016/0732-8893(92)90068-5. [DOI] [PubMed] [Google Scholar]
- Nettleman M. D., Jones R. B. Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis. JAMA. 1988 Jul 8;260(2):207–213. [PubMed] [Google Scholar]
- Schachter J., Stamm W. E., Quinn T. C., Andrews W. W., Burczak J. D., Lee H. H. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol. 1994 Oct;32(10):2540–2543. doi: 10.1128/jcm.32.10.2540-2543.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shafer M. A., Schachter J., Moscicki A. B., Weiss A., Shalwitz J., Vaughan E., Millstein S. G. Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA. 1989 Nov 10;262(18):2562–2566. [PubMed] [Google Scholar]
- Thejls H., Gnarpe J., Gnarpe H., Larsson P. G., Platz-Christensen J. J., Ostergaard L., Victor A. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med. 1994 Oct;70(5):300–303. doi: 10.1136/sti.70.5.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Washington A. E., Johnson R. E., Sanders L. L., Jr Chlamydia trachomatis infections in the United States. What are they costing us? JAMA. 1987 Apr 17;257(15):2070–2072. [PubMed] [Google Scholar]
- Washington A. E., Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA. 1991 Nov 13;266(18):2565–2569. [PubMed] [Google Scholar]
- Werner M. J., Biro F. M. Urinary leukocyte esterase screening for asymptomatic sexually transmitted disease in adolescent males. J Adolesc Health. 1991 Jun;12(4):326–328. doi: 10.1016/0197-0070(91)90008-a. [DOI] [PubMed] [Google Scholar]